| Literature DB >> 34472726 |
Izumita Kuniyuki1, Takuma Hisaoka2, Ryoukichi Ikeda2, Jun Suzuki2, Naoko Sato1, Ryo Tagaino1, Tomonori Kambayashi2, Ai Hirano-Kawamoto2, Jun Ohta2, Akira Ohkoshi2, Ryo Ishii2, Naru Shitraishi3, Kengo Kato2, Shigeto Koyama1, Keiichi Sasaki3, Yukio Katori2.
Abstract
BACKGROUND: The palatal augmentation prosthesis (PAP) is an intraoral prosthesis used in the treatment of dysphagia. AIM: The objective of the study is to examine the effect of PAP using tongue pressure and the Videofluoroscopic Dysphagia Scale (VDS) to understand the precise mechanism for improvement in swallowing function with PAP for oral cancer at retrospective survey. METHODS ANDEntities:
Keywords: dysphagia; oral cancer; palatal augmentation prosthesis; swallowing; videofluoroscopic dysphagia scale
Mesh:
Year: 2021 PMID: 34472726 PMCID: PMC9327658 DOI: 10.1002/cnr2.1516
Source DB: PubMed Journal: Cancer Rep (Hoboken) ISSN: 2573-8348
FIGURE 1Palatal augmentation prosthesis (PAP). (A) PAP (tongue side), (B) PAP (hard plate side), (C) Without PAP, (D) With PAP
The items of the videofluoroscopic dysphagia scale (VDS)
| Parameter | Coded value | Score | Parameter | Coded value | Score | ||
|---|---|---|---|---|---|---|---|
| Lip closure | Intact | 0 | 4 | Triggering of pharyngeal swallowing | Normal | 0 | 4.5 |
| Inadequate | 2 | Delayed | 4.5 | ||||
| None | 4 | Vallecular residue | None | 0 | 6 | ||
| Bolus formation | Intact | 0 | 6 | <10% | 2 | ||
| Inadequate | 3 | 10%–50% | 4 | ||||
| None | 6 | >50% | 6 | ||||
| Mastication | Intact | 0 | 8 | Laryngeal elevation | Normal | 0 | 9 |
| Inadequate | 4 | Impaired | 9 | ||||
| None | 8 | Pyriform sinus residue | None | 0 | 13.5 | ||
| Apraxia | None | 0 | 4.5 | <10% | 4.5 | ||
| Mild | 1.5 | 10%–50% | 9 | ||||
| Moderate | 3 | >50% | 13.5 | ||||
| Severe | 4.5 | Coating on the pharyngeal wall | No | 0 | 9 | ||
| Tongue to palate contact | Intact | 0 | 10 | Yes | 9 | ||
| Inadequate | 5 | Pharyngeal transit time | ≤1.0 s | 0 | 6 | ||
| None | 10 | >1.0 s | 6 | ||||
| Premature bolus loss | None | 0 | 4.5 | Aspiration | None | 0 | 12 |
| <10% | 1.5 | Supraglottic penetration | 6 | ||||
| 10%–50% | 3 | Subglottic aspiration | 12 | ||||
| >50% | 4.5 | Pharyngeal phase | 60 | ||||
| Oral transit time | ≤1.5 s | 0 | 3 | ||||
| >1.5 s | 3 | ||||||
| Oral phase | 40 | Total | 100 | ||||
The patients' characteristics (First VF means the period from primary treatment to swallowing center consultation. Span means the period from primary assessment to palatal augmentation prosthesis assessment)
| Sex | Age | Primary | TMN | Stage | Surgical field | Neck dissection | Free flap reconstruction | Chemoradiation therapy | First VF | Span |
|---|---|---|---|---|---|---|---|---|---|---|
| M | 29 | Tongue | T3N1M0 | III | Subtotal glossectomy | Bilateral | Y | N | 3 m | 0.5 |
| M | 35 | Tongue | T3N0M0 | III | Subtotal glossectomy | Bilateral | Y | N | 1 m | 5 |
| F | 56 | Lower gingiva | T4aN0M0 | IVa | Segmental mandibulectomy | Bilateral | Y | N | 1 m | 11 |
| F | 61 | Tongue | T4aN0M0 | IVa | Total glossectomy | Bilateral | Y | N | 4 m | 8 |
| F | 62 | Floor of mouth | T4aN0M0 | IVa | Segmental mandibulectomy | Right | Y | N | 3 m | 4 |
| F | 64 | Tongue | T3N0M0 | III | Total glossectomy | Bilateral | Y | Y | 1 m | 1 |
| F | 65 | Tongue | T1N0M0 | I | Subtotal glossectomy | Bilateral | Y | N | 4 m | 8 |
| M | 66 | Tongue | T3N1M0 | IVa | Subtotal glossectomy | Bilateral | Y | Y | 8 y 7 m | 5 |
| M | 67 | Tongue | T3N0M0 | III | Subtotal glossectomy | Bilateral | Y | N | 9 y 5 m | 0 |
| M | 69 | Floor of mouth | T1N2cM0 | IVa | Marginal mandibulectomy | Bilateral | N | Y | 1 y | 3 |
| M | 70 | Tongue | T4aN0M0 | IVa | Subtotal glossectomy and segmental mandibulectomy | Bilateral | Y | Y | 1 m | 2 |
| M | 74 | Tongue | T2N1M0 | IVa | Hemiglossectomy | Right | Y | Y | 7 m | 1 |
| M | 78 | Tongue | T2N0M0 | II | Partial glossectomy | Bilateral | Y | Y | 21y | 5 |
| M | 82 | Tongue | T2N1M0 | III | Partial glossectomy | Left | N | N | 3 m | 6 |
| M | 82 | Tongue | T3N0M0 | III | Hemiglossectomy | Right | Y | N | 23y | 4 |
FIGURE 2The tongue pressure without (left) and with (right) palatal augmentation prosthesis (PAP) n = 15
The videofluoroscopic dysphagia scale (VDS) score before and after the intervention
| Before intervention | After intervention |
| |
|---|---|---|---|
| Lip closure | 0.3 ± 0.8 | 0.1 ± 0.2 | .180 |
| Bolus formation | 3.8 ± 1.3 | 3.1 ± 1.5 | .053 |
| Mastication | 5.2 ± 1.4 | 4.3 ± 2.0 | .058 |
| Apraxia | 2.1 ± 0.9 | 1.8 ± 0.9 | .605 |
| Tongue to palate contact | 5.8 ± 2.3 | 3.9 ± 2.6 | .010* |
| Premature bolus loss | 1.4 ± 1.4 | 1.4 ± 1.6 | .944 |
| Oral transit time | 2.4 ± 0.8 | 1.9 ± 0.9 | .096 |
| Triggering of pharyngeal swallowing | 2.8 ± 0.8 | 2.9 ± 1.4 | .660 |
| Vallecular residue | 1.9 ± 1.4 | 2.2 ± 1.4 | .131 |
| Laryngeal elevation | 6.6 ± 2.7 | 5.5 ± 3.3 | .196 |
| Pyriform sinus residue | 4.4 ± 4.2 | 2.6 ± 2.9 | .018* |
| Coating on the pharyngeal wall | 4.5 ± 4.3 | 4.3 ± 4.1 | .577 |
| Pharyngeal transit time | 2.5 ± 2.6 | 2.8 ± 2.3 | .317 |
| Aspiration | 3.0 ± 3.9 | 3.6 ± 4.2 | .858 |
| Oral phase | 21.0 ± 6.3 | 16.5 ± 7.5 | .015* |
| Pharyngeal phase | 25.6 ± 15.2 | 23.6 ± 17.6 | .388 |
| Total | 46.7 ± 19.2 | 40.1 ± 21.4 | .045* |
Note: Asterisk indicated p < .05. n = 13.
FIGURE 3pharyngeal residue without (left) and with (right) palatal augmentation prosthesis (PAP)
The videofluoroscopic dysphagia scale (VDS) score before and after the intervention with or without CRT
| CRT + | CRT − | |||
|---|---|---|---|---|
| Before intervention | After intervention | Before intervention | After intervention | |
| Lip closure | 0.1 ± 0.3 | 0.4 ± 1.1 | 0.0 ± 0.0 | 0.3 ± 0.7 |
| Bolus formation | 4.0 ± 1.7 | 4.0 ± 1.7 | 2.8 ± 1.3 | 3.6 ± 1.1 |
| Mastication | 4.9 ± 1.8 | 5.3 ± 1.7 | 4.1 ± 1.8 | 5.0 ± 1.1 |
| Apraxia | 1.8 ± 1.0 | 2.6 ± 0.7 | 1.9 ± 0.8 | 1.7 ± 0.8 |
| Tongue to palate contact | 5.0 ± 3.2 | 5.3 ± 3.1 | 3.9 ± 2.2 | 5.4 ± 2.3 |
| Premature bolus loss | 2.7 ± 1.5 | 1.9 ± 1.4 | 0.9 ± 1.1 | 1.4 ± 1.5 |
| Oral transit time | 2.2 ± 1.2 | 2.3 ± 0.8 | 1.9 ± 0.6 | 2.3 ± 0.9 |
| Triggering of pharyngeal swallowing | 3.8 ± 0.8 | 3.3 ± 1.1 | 2.5 ± 1.3 | 2.5 ± 0.6 |
| Vallecular residue | 3.1 ± 1.2 | 3.1 ± 1.0 | 1.9 ± 1.3 | 1.2 ± 0.9 |
| Laryngeal elevation | 8.0 ± 1.5 | 7.3 ± 2.0 | 4.3 ± 3.4 | 5.8 ± 2.6 |
| Pyriform sinus residue | 4.6 ± 2.8 | 5.5 ± 4.1 | 1.2 ± 2.5 | 2.5 ± 3.8 |
| Coating on the pharyngeal wall | 6.5 ± 2.3 | 7.0 ± 2.4 | 3.0 ± 4.0 | 2.3 ± 3.9 |
| Pharyngeal transit time | 4.8 ± 1.8 | 3.7 ± 2.3 | 1.8 ± 1.6 | 1.6 ± 2.2 |
| Aspiration | 4.2 ± 5.1 | 5.3 ± 4.3 | 3.3 ± 3.9 | 2.4 ± 3.0 |
| Oral phase | 20.7 ± 8.7 | 21.9 ± 7.8 | 15.5 ± 5.8 | 19.7 ± 5.5 |
| Pharyngeal phase | 35.0 ± 11.9 | 35.1 ± 9.9 | 18.0 ± 15.0 | 18.4 ± 11.8 |
| Total | 55.7 ± 13.7 | 57.0 ± 15.1 | 33.5 ± 18.9 | 38.1 ± 14.8 |
The videofluoroscopic dysphagia scale (VDS) score before and after the intervention unilateral or bilateral neck dissection
| Unilateral neck dissection | Bilateral neck dissection | |||
|---|---|---|---|---|
| Before intervention | After intervention | Before intervention | After intervention | |
| Lip closure | 0.0 ± 0.0 | 0.2 ± 0.3 | 0.1 ± 0.2 | 0.4 ± 1.0 |
| Bolus formation | 3.3 ± 1.9 | 2.8 ± 1.0 | 3.3 ± 1.5 | 4.1 ± 1.3 |
| Mastication | 3.3 ± 1.7 | 5.3 ± 0.0 | 4.8 ± 1.7 | 5.1 ± 1.6 |
| Apraxia | 1.8 ± 1.0 | 1.5 ± 0.7 | 1.9 ± 0.9 | 2.3 ± 0.8 |
| Tongue to palate contact | 4.6 ± 2.5 | 3.3 ± 1.9 | 4.2 ± 2.7 | 6.1 ± 2.4 |
| Premature bolus loss | 1.8 ± 1.3 | 1.4 ± 1.1 | 1.6 ± 1.7 | 1.7 ± 1.6 |
| Oral transit time | 1.8 ± 1.0 | 1.5 ± 1.0 | 2.1 ± 0.8 | 2.6 ± 0.5 |
| Triggering of pharyngeal swallowing | 3.0 ± 1.2 | 2.6 ± 0.8 | 3.0 ± 1.3 | 2.9 ± 1.0 |
| Vallecular residue | 3.2 ± 1.8 | 2.2 ± 1.1 | 2.1 ± 1.2 | 1.9 ± 1.5 |
| Laryngeal elevation | 6.0 ± 4.2 | 5.3 ± 2.9 | 5.7 ± 3.1 | 6.8 ± 2.3 |
| Pyriform sinus residue | 3.8 ± 4.3 | 3.8 ± 4.7 | 2.1 ± 2.6 | 3.7 ± 4.0 |
| Coating on the pharyngeal wall | 3.8 ± 4.5 | 1.5 ± 1.7 | 4.6 ± 3.6 | 5.2 ± 4.3 |
| Pharyngeal transit time | 3.0 ± 2.6 | 2.0 ± 1.6 | 3.0 ± 2.2 | 2.5 ± 2.7 |
| Aspiration | 2.5 ± 3.0 | 3.0 ± 1.2 | 4.1 ± 4.7 | 3.8 ± 4.3 |
| Oral phase | 16.4 ± 7.7 | 16.0 ± 3.4 | 18.0 ± 7.5 | 22.3 ± 6.4 |
| Pharyngeal phase | 25.2 ± 18.9 | 20.3 ± 12.1 | 24.6 ± 15.8 | 26.8 ± 14.3 |
| Total | 41.6 ± 23.9 | 36.3 ± 13.9 | 42.7 ± 19.7 | 49.0 ± 17.7 |